BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34242728)

  • 21. [Delayed diagnosis of primary hyperoxaluria in a young patient with advanced chronic renal failure].
    Martín M; Martín Reyes G; Torres de Rueda A; Toledo Rojas R; Jironda C; García I; García de la Oliva T; Pérez Vaca ML; Hernández D
    Nefrologia; 2011; 31(2):227-9. PubMed ID: 21461022
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.
    Tang X; Voskoboev NV; Wannarka SL; Olson JB; Milliner DS; Lieske JC
    Am J Nephrol; 2014; 39(5):376-82. PubMed ID: 24776840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The primary hyperoxalurias.
    Hoppe B; Beck BB; Milliner DS
    Kidney Int; 2009 Jun; 75(12):1264-1271. PubMed ID: 19225556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing clinical outcome in patients with primary hyperoxaluria type 1.
    Fargue S
    Kidney Int; 2014 Dec; 86(6):1074-6. PubMed ID: 25427081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current approaches to the management of primary hyperoxaluria.
    Cochat P; Basmaison O
    Arch Dis Child; 2000 Jun; 82(6):470-3. PubMed ID: 10833178
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y; Parnham AP; Falk MC; Burke JR; Nicol D; Yamanaka J; Lynch SV; Strong RW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pronounced soft tissue calcinosis in primary hyperoxaluria Type 1].
    Engel M; Schulz M
    Med Klin (Munich); 2001 Nov; 96(11):689. PubMed ID: 11760658
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved growth velocity with intensive dialysis. Consequence or coincidence?
    Katz A; Bock GH; Mauer M
    Pediatr Nephrol; 2000 Aug; 14(8-9):710-2. PubMed ID: 10955912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of primary hyperoxaluria: clues to innovative treatments.
    Dindo M; Conter C; Oppici E; Ceccarelli V; Marinucci L; Cellini B
    Urolithiasis; 2019 Feb; 47(1):67-78. PubMed ID: 30430197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adult type I primary hyperoxaluria: 2 cases confirmed by liver biopsy at end-stage renal insufficiency].
    Schillinger F; Mahmoud M; Montagnac R; Collin P; Milcent T
    Nephrologie; 1990; 11(4):217-21. PubMed ID: 2074921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular aetiology of primary hyperoxaluria type 1.
    Danpure CJ
    Nephron Exp Nephrol; 2004; 98(2):e39-44. PubMed ID: 15499210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria or oxalosis-unrelated renal diseases.
    Marangella M; Petrarulo M; Vitale C; Daniele PG; Sammartano S; Cosseddu D; Linari F
    Clin Sci (Lond); 1991 Oct; 81(4):483-90. PubMed ID: 1657494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
    Martin-Higueras C; Ludwig-Portugall I; Hoppe B; Kurts C
    Nephrol Dial Transplant; 2019 Jun; 34(6):908-914. PubMed ID: 30169827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: Single-center experience.
    Lorenzo V; Alvarez A; Torres A; Torregrosa V; Hernández D; Salido E
    Kidney Int; 2006 Sep; 70(6):1115-9. PubMed ID: 16912707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel AGXT gene mutation in a Sri Lankan family with primary Hyperoxaluria type 1.
    Sirisena ND; Tantrigoda NH; Kariyawasam KJ; Jayasekara RW; Dissanayake VH
    Nephrology (Carlton); 2016 Jan; 21(1):75-6. PubMed ID: 26693850
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary hyperoxaluria: A review].
    Bouzidi H; Majdoub A; Daudon M; Najjar MF
    Nephrol Ther; 2016 Nov; 12(6):431-436. PubMed ID: 27372182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria.
    Morgan SH; Purkiss P; Watts RW; Mansell MA
    Nephron; 1987; 46(3):253-7. PubMed ID: 3306417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria.
    Onaca N; Sanchez EQ; Melton LB; Netto GJ; Glastad KA; Martin PA; Ueno T; Levy MF; Goldstein RM; Klintmalm GB
    Transplantation; 2005 Aug; 80(3):421-4. PubMed ID: 16082341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cell biology of primary hyperoxaluria type 1.
    Danpure CJ
    Clin Investig; 1994 Sep; 72(9):725-7. PubMed ID: 7849461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.